Health Companies
Latest Deals in Health
$50M
Nanit, a U.S.-based company, secured $50 million in a growth funding round led by Springcoast Partners. The funding will enhance its AI-powered parenting intelligence system, addressing the need for individualized insights in early childhood development.Investors: Springcoast Partners
$30M
Valerie Health, co-founded by Peter Shalek and Nitin Joshi, raised $30 million in a Series A funding led by Redpoint Ventures. The company aims to automate healthcare workflows for independent doctors, addressing the gap in patient care in the U.S. Total funding now stands at $39 million.Investors: Redpoint Ventures
$30M
Valerie Health, co-founded by Peter Shalek and Nitin Joshi, raised $30 million in a Series A funding led by Redpoint Ventures. The company aims to automate healthcare workflows for independent doctors, addressing the gap in patient care in the U.S. Total funding now stands at $39 million.Investors: Redpoint Ventures
$5.4M
Mindoo has secured โฌ5 million in seed financing to develop AI agents that automate healthcare workflows, addressing staffing challenges. The investment comes from 6dc, Syndicate One, and strategic angel investors, aiming to enhance efficiency in hospitals across Belgium and Germany.Investors: 6dc, Syndicate One
$130M
Chai Discovery, a San Francisco-based biotech, secured $130 million at a $1.3 billion valuation to develop a computer-aided design suite for molecules. Key investors include Oak HC/FT and General Catalyst. The funding aims to enhance drug discovery efficiency, targeting complex diseases.Investors: Oak HC/FT, General Catalyst
$25.92M
Jutro Medical raised a โฌ24m Series A extension led by Warsaw Equity Group, totaling โฌ36m. The company addresses outdated GP practices in Poland by integrating clinics into an AI-driven platform, enhancing patient care and reducing administrative burdens.Investors: Warsaw Equity Group
$5.4M
Mindoo has secured โฌ5 million in seed financing to provide configurable AI agents for healthcare workflows, addressing staffing challenges. Lead investors include 6dc and Syndicate One. The platform aims to ease pressure on clinical teams and is currently deployed in Belgium and Germany.Investors: 6dc, Syndicate One
$0.918M
Smile Genius, a dental-tech platform, has raised โฌ850k to enhance clinic-lab workflows. Key investors include Enterprise Ireland and Haatch (UK). The platform, used by over 1,200 clinics, aims to double its presence by 2026, addressing major industry challenges.Investors: Enterprise Ireland, Haatch
$38.88M
Warsaw-based Jutro Medical raised โฌ24 million in funding led by Warsaw Equity Group. The company addresses primary care challenges with AI tools, aiming to streamline operations and improve access. The total raised in Series A is โฌ36 million, supporting clinic acquisitions and expansion in Europe.Investors: Warsaw Equity Group
$25.92M
Jutro Medical, a Warsaw-based AI-first primary care operator, raised โฌ24 million led by Warsaw Equity Group, totaling โฌ36 million. The funding addresses primary care challenges like workforce shortages and aims to expand clinic acquisitions in Poland and Europe.Investors: Warsaw Equity Group
$130M
Chai Discovery, an OpenAI-backed biotech startup, raised $130 million in a Series B round at a $1.3 billion valuation. The funding, led by General Catalyst and Oak HC/FT, aims to enhance drug development using AI, with total funding now exceeding $225 million.Investors: General Catalyst, Oak HC/FT
$130M
Chai Discovery Inc., an AI startup focused on accelerating drug development, raised $130 million in a funding round led by Oak HC/FT and General Catalyst, with participation from OpenAI Group PBC and Thrive Capital.Investors: Oak HC/FT, General Catalyst, OpenAI Group PBC, Thrive Capital
$35M
Ritten, an AI-powered system for behavioral health providers, raised $35 million in a Series B funding round led by Five Elms Capital. The funds will support expansion across mental health and addiction treatment services.Investors: Five Elms Capital
Relation Therapeutics has raised $26 million from existing investors Nventures, DCVC, and Magnetic Ventures to enhance its AI-driven drug discovery platform, aimed at improving confidence in disease biology.
Investors: Nventures, DCVC, Magnetic Ventures
$130M
Chai Discovery, a San Francisco-based AI company, raised $130 million in Series B funding at a $1.3 billion valuation. The round was led by Oak HC/FT and General Catalyst, addressing the prediction and reprogramming of biochemical interactions.Investors: Oak HC/FT, General Catalyst
$4.5M
a2z radiology ai has secured $4.5 million in seed funding from Khosla Ventures and Seax Ventures to enhance the deployment of its FDA-cleared CT triage product and advance imaging interpretation research.Investors: Khosla Ventures, Seax Ventures